DENVILLE, NJ
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION, founded in 1996, is a community nonprofit in the Diseases & Disorders sector that reported $1.3M in total revenue in fiscal year 2023. Revenue grew 20% year-over-year, indicating healthy expansion. The organization ran a surplus of $246K, a strong 19% operating margin.
TO PROVIDE SUPPORT, ADVOCACY AND EDUCATION TO PATIENTS, FAMILIES, THE MEDICAL COMMUNITY AND THE PUBLIC ABOUT HYPERTROPHIC CARDIOMYOPATHY, WHILE SUPPORTING RESEARCH AND FOSTERING THE DEVELOPMENT OF TREATMENTS.
HCMA RECOGNIZED CENTER OF EXCELLENCE PROGRAM:HYPERTROPHIC CARDIOMYOPATHY IS A COMPLICATED DIAGNOSIS REQUIRING SPECIALTY MANAGEMENT STRATEGIES. HCM IMPACTS AN ESTIMATED ONE IN 250 IN THE GENERAL...
HCMA RECOGNIZED CENTER OF EXCELLENCE PROGRAM:HYPERTROPHIC CARDIOMYOPATHY IS A COMPLICATED DIAGNOSIS REQUIRING SPECIALTY MANAGEMENT STRATEGIES. HCM IMPACTS AN ESTIMATED ONE IN 250 IN THE GENERAL POPULATION. IT IS CURRENTLY SIGNIFICANTLY UNDERDIAGNOSED, WITH ONLY AN ESTIMATED 150,000 INDIVIDUALS IN THE UNITED STATES CURRENTLY IN TREATMENT FOR THE DISEASE. CARE FOR HCM REQUIRES MULTIPLE SUBSPECIALTY CARE MODALITIES INCLUDING BUT NOT LIMITED TO IMAGING CARDIOLOGY, INTERVENTIONAL CARDIOLOGY, ELECTROPHYSIOLOGY, CARDIAC SURGERY, GENETICS, PSYCHOSOCIAL SERVICES, AND CARDIAC OVERSIGHT FOR NONCARDIAC PROCEDURES, INCLUDING PREGNANCY ORTHOPEDIC ISSUES AND OTHER GENERAL MEDICAL NEEDS. THE HCMA HAS 50 RECOGNIZED CENTERS OF EXCELLENCE PROGRAMS IN THE UNITED STATES, WITH 17 UNDER REVIEW AND INTERNATIONAL PROGRAMMING BEING DEVELOPED. CREATION OF THESE PROGRAMS TAKES RELATIONSHIP BUILDING, PROGRAM EVALUATION AND ADMINISTRATIVE SUPPORT. PATIENTS CARED FOR IN THIS MODEL HAVE BETTER OUTCOMES THAN THOSE TREATED IN LOW-VOLUME CENTERS. THIS PROGRAM DIRECTLY LEADS TO PATIENT SAFETY AND OPTIMAL OUTCOMES.
HCMA PATIENT INTAKE AND NAVIGATION SERVICES:THE HCMA ALLOWS EACH INDIVIDUAL DIAGNOSED WITH THE CONDITION TO CONTACT THE OFFICE (PHONE, EMAIL , IN PERSON, OR ONLINE THROUGH VIDEO CONFERENCING) AND...
HCMA PATIENT INTAKE AND NAVIGATION SERVICES:THE HCMA ALLOWS EACH INDIVIDUAL DIAGNOSED WITH THE CONDITION TO CONTACT THE OFFICE (PHONE, EMAIL , IN PERSON, OR ONLINE THROUGH VIDEO CONFERENCING) AND PARTICIPATE IN AN INTAKE CALL, WHICH THEN ALLOWS FOR UNDERSTANDING WHERE THE INDIVIDUAL IS COMING TO US REGARDING THEIR DISEASE PROCESS, ACCESS TO SPECIALTY CARE, EMOTIONAL SUPPORT, ADVOCACY SERVICES, AND MORE. THIS IS A VERY LABOR-INTENSIVE PORTION OF OUR WORK, REQUIRING INDIVIDUAL COMMUNICATION AND FOLLOW-UP. WE HAVE USED THIS MODEL OF SERVICE SINCE OUR FOUNDING IN 1996. IT HAS EVOLVED AS THE ORGANIZATION HAS, AND TO DATE, 20,000 INDIVIDUALS HAVE PARTICIPATED IN THE PROCESS.
PATIENT EDUCATION BIGHEARTED WARRIOR WEBINAR PROGRAM:IN 2020, WE MOVED TO A VIRTUAL EDUCATION MODEL, WHICH HAS NOW SPANNED NEARLY FOUR YEARS WITH OVER 30 SEGMENTS OF EDUCATIONAL MATERIAL CREATED...
PATIENT EDUCATION BIGHEARTED WARRIOR WEBINAR PROGRAM:IN 2020, WE MOVED TO A VIRTUAL EDUCATION MODEL, WHICH HAS NOW SPANNED NEARLY FOUR YEARS WITH OVER 30 SEGMENTS OF EDUCATIONAL MATERIAL CREATED. EACH WEBINAR IS ORGANIZED BY EITHER THE HCMA-RECOGNIZED CENTER OR THE SUBTOPICS SUCH AS PEDIATRICS, GENETICS, OR OTHER SIMILAR TOPICS. THESE PROGRAMS ARE FREE TO ALL AND HAVE PROVIDED AN EDUCATIONAL OPPORTUNITY REGARDLESS OF GEOGRAPHIC LOCATION. THESE PROGRAMS ARE HELD TYPICALLY MONTHLY AND SOMETIMES MORE OFTEN THAN THAT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,326,262 | $1,106,885 | +0.2% |
| Expenses | $1,080,476 | $796,317 | +0.4% |
| Net Income | $245,786 | $310,568 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LISA SALBERG | CEO/VICE CHAIR | 40.00 |
Officer
Director
|
$98,908 | $6,092 | $105,000 |
| GORDON FOX PHD | CHAIR | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| ADAM SALBERG | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ROB LORFINK | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| AMIT KALIA PHD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ROSEMARY CONLON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BILLUR DOWSE | DIRECTOR | 10.00 |
Director
|
$0 | $0 | $0 |
| MARTIN MARON MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MIKE LYNCH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN O'CONNOR MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ISAAC RODRIGUEZ-CHAVEZ PHD MHS MS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BILL ROSSI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD MELIA PHD EMERITUS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $1,326,262 | $1,080,476 | $1,398,852 | $245,786 |
| 2022 | $1,106,885 | $796,317 | $1,085,584 | $310,568 |
| 2021 | $804,960 | $531,813 | $577,031 | $273,147 |
| 2020 | $390,972 | $374,280 | $313,163 | $16,692 |
| 2019 | $320,578 | $191,775 | $296,471 | $128,803 |
| 2018 | $355,678 | $192,098 | $167,668 | $163,580 |
Compare HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION with other nonprofits in New Jersey and across the country.